UNSPSC 51342708: Interferon alfa-n1

This classification denotes an interferon, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47BPR3V3MP. European Medicines Agency schedules Interferon alfa-n1 in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20625. As of Q4 2014, INTERFERON ALFA-N1 remains the US FDA Preferred Term for this commodity. Interferon alfa-n1 bears US NLM identifiers UMLS ID C0699817 and NCI Concept Code C2220. SMILES: NONE.

UNSPSC 51342708 Interferon alfa-n1 is a Commodity code, but recent state and local solicitations tagged with this code show little activity aligned to its nominal scope. The recent opportunities listed under this code—including Seminole County's procurement of naloxone and drug deactivation systems, the Texas HHS Commission's request for information on direct-to-manufacturer prescription programs, the City of Tampa's bid for medical and first aid supplies, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products—address pharmaceutical procurement, medical supplies distribution, and pharmacy benefit management more broadly. None of these solicitations specifically target interferon alfa-n1 or biologics in the interferon family. The issuing bodies represent diverse state and local government functions: county health departments (Seminole County), state health and human services agencies (Texas HHS Commission, Minnesota Department of Administration), municipal purchasing departments (City of Tampa), and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The geographic spread spans Florida, Texas, Minnesota, and Oregon, with representation from municipal, state, and multi-state cooperative procurement vehicles.

The most recent opportunities reflect emergency response and population health spending rather than specialized biologic procurement. Seminole County's IFB 60459723LAS (due July 26, 2023) sought 1,900 units of naloxone annually for community health initiatives with quarterly deliveries. The City of Tampa's IFB 26P00145 (due March 13, 2026) solicited 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00, designated as a sheltered market opportunity with a 5% bid discount for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance's RFP (due March 26, 2026) established multiple contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) effective July 1, 2026. The Texas HHS Commission's RFI HHS0017013 (response due April 3, 2026) explored vendor capabilities for direct-to-manufacturer prescription programs. The mismatch between the code's nominal scope and actual procurement activity suggests this code shows minimal relevant activity for firms pursuing interferon alfa-n1 opportunities in state and local markets.